Business
INOVIO to Present at the 2023 Jefferies Healthcare Conference
PLYMOUTH MEETING, Pa., May 25, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to
About this update from Inovio Pharmaceuticals, Inc.
[{"type":"text","content":"PLYMOUTH MEETING, Pa., May 25, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO, and Dr. Michael Sumner, CMO, will present at the 2023 Jefferies Healthcare Conference.\n2023 Jefferies Healthcare ConferenceDate: Friday, June 9, 2023Time: 8:00 AM ETFormat: Fireside Chat\nDuring the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.\nA webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. A replay of the webcast will be available for 90 days after the date of the presentation.\nAbout INOVIO\nINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.\nContacts\nMedia: Jennie Willson (267) 429-8567 [email protected]: Thomas Hong (267) 440-4298 [email protected]\n \n View original content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-2023-jefferies-healthcare-conference-301834353.html\nSOURCE INOVIO Pharmaceuticals, Inc.","length":3057,"tagName":"div"}]